Seungtaek Kim to Animals
This is a "connection" page, showing publications Seungtaek Kim has written about Animals.
Connection Strength
0.121
-
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351). Microbiol Spectr. 2021 09 03; 9(1):e0047221.
Score: 0.028
-
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. J Med Virol. 2021 03; 93(3):1403-1408.
Score: 0.026
-
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrob Agents Chemother. 2020 06 23; 64(7).
Score: 0.026
-
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay. Proc Natl Acad Sci U S A. 2021 07 27; 118(30).
Score: 0.007
-
Comparison of Digital PCR and Quantitative PCR with Various SARS-CoV-2 Primer-Probe Sets. J Microbiol Biotechnol. 2021 03 28; 31(3):358-367.
Score: 0.007
-
Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments. Bioorg Med Chem Lett. 2021 05 01; 39:127885.
Score: 0.007
-
Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. Phytomedicine. 2021 Jun; 86:153440.
Score: 0.007
-
Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2. Bioorg Med Chem Lett. 2021 01 01; 31:127667.
Score: 0.007
-
Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody. Int J Mol Sci. 2019 Oct 12; 20(20).
Score: 0.006